CD79A and neoplasm: IgA can activate neutrophils by binding to FcαRI and mediate their killing effect on tumor cells, such as ADCC (antibody-dependent cell cycotoxicity), cell phagocytosis, immune cell recruitment, the release of cytotoxic molecules, and cell necrosis.